165 related articles for article (PubMed ID: 3025400)
21. Pancreatic Neuroendocrine Tumor Secreting Vasoactive Intestinal Peptide and Dopamine With Pulmonary Emboli: A Case Report.
Nilubol N; Freedman EM; Quezado MM; Patel D; Kebebew E
J Clin Endocrinol Metab; 2016 Oct; 101(10):3564-3567. PubMed ID: 27583474
[TBL] [Abstract][Full Text] [Related]
22. A case of vasoactive intestinal peptide-secreting tumor (VIPoma) arising from MEN1 inactivation which recurred 15 years after the initial resection.
Sakurai M; Wakabayashi T; Kondo Y; Ikeda E; Watanabe K; Takei A; Okazaki H; Okada K; Ebihara K; Kakiuchi N; Ogawa S; Fukushima N; Ishibashi S
Endocr J; 2023 Jun; 70(6):573-579. PubMed ID: 36889692
[TBL] [Abstract][Full Text] [Related]
23. [Pancreatic vipomas. Apropos of 3 operated cases].
Jaeck D; Paris F; Adloff M; Thibaud D; Rico E; Bruant P; Baumann R; Aprosio N; Weill Bousson M; Weill JP
Chirurgie; 1986; 112(2):142-7. PubMed ID: 2824141
[No Abstract] [Full Text] [Related]
24. [The VIP-secreting tumor as a differential diagnosis of protracted diarrhea in pediatrics].
Reindl T; Degenhardt P; Luck W; Riebel T; Sarioglu N; Henze G; Driever PH
Klin Padiatr; 2004; 216(5):264-9. PubMed ID: 15455292
[TBL] [Abstract][Full Text] [Related]
25. Vasoactive intestinal polypeptide-secreting tumours: biology and therapy.
Park SK; O'Dorisio MS; O'Dorisio TM
Baillieres Clin Gastroenterol; 1996 Dec; 10(4):673-96. PubMed ID: 9113317
[TBL] [Abstract][Full Text] [Related]
26. Benign pancreatic vipoma.
Alvite-Canosa M; Alonso-Fernández L; Seoane-López M; Pérz-Grobas J; Berdeal-Díaz M; Carral-Freire M; Bouzón-Alejandro A; Gómez-Dovigo A; Aguirrezabalaga-González J
Rev Esp Enferm Dig; 2011 Apr; 103(4):224-5. PubMed ID: 21526882
[No Abstract] [Full Text] [Related]
27. Multiple endocrine neoplasia, type 1, with pancreatic cholera.
Namihira Y; Achord JL; Subramony C
Am J Gastroenterol; 1987 Aug; 82(8):794-7. PubMed ID: 2886044
[TBL] [Abstract][Full Text] [Related]
28. Giant metastatic VIPoma in the liver.
Dohmen K; Fukushima N; Fujisaki T; Iwakiri R; Yamano Y; Nagano M; Wada K; Kodama K; Iwata Y; Hachimine K
Gastroenterol Jpn; 1991 Aug; 26(4):530-5. PubMed ID: 1655553
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic VIPomas: subject review and one institutional experience.
Ghaferi AA; Chojnacki KA; Long WD; Cameron JL; Yeo CJ
J Gastrointest Surg; 2008 Feb; 12(2):382-93. PubMed ID: 17510774
[TBL] [Abstract][Full Text] [Related]
30. Pancreatic vasoactive intestinal polypeptide-oma as a cause of secretory diarrhoea.
Masel SL; Brennan BA; Turner JH; Cullingford GL; Cullen DJ
J Gastroenterol Hepatol; 2000 Apr; 15(4):457-60. PubMed ID: 10824894
[TBL] [Abstract][Full Text] [Related]
31. Watery diarrhea syndrome. Two unusual cases and further evidence that VIP is a humoral mediator.
Cooperman AM; Desantis D; Winkelman E; Farmer R; Eversman J; Said S
Ann Surg; 1978 Mar; 187(3):325-8. PubMed ID: 205179
[TBL] [Abstract][Full Text] [Related]
32. Percutaneous Cryoablation of Recurrent Pancreatic Mass for Life-Threatening Pancreatic VIPoma Syndrome: A Case Report.
Eng K; Wiseman D; Van Uum S; Quan D; Sanatani M; Mujoomdar A
Cardiovasc Intervent Radiol; 2021 Jan; 44(1):163-166. PubMed ID: 32914368
[TBL] [Abstract][Full Text] [Related]
33. Ventricular fibrillation resulting from electrolyte imbalance reveals vipoma in MEN1 syndrome.
Cavalli T; Giudici F; Santi R; Nesi G; Brandi ML; Tonelli F
Fam Cancer; 2016 Oct; 15(4):645-9. PubMed ID: 27071757
[TBL] [Abstract][Full Text] [Related]
34. Intractable and dramatic diarrhea in liver transplantation recipient with vasoactive intestinal peptide-producing tumor after split liver transplantation: a case report.
Haiqing W; Jiayin Y; Jian Y; Lunan Y
Transplant Proc; 2015; 47(1):171-3. PubMed ID: 25596962
[TBL] [Abstract][Full Text] [Related]
35. [Endocrine pancreas tumors. Progress in diagnosis and surgical therapy].
Heberer G; Teichmann RK
MMW Munch Med Wochenschr; 1982 Oct; 124(43):945-7. PubMed ID: 6292707
[No Abstract] [Full Text] [Related]
36. Vasoactive intestinal peptide secreting tumors. Pathophysiological and clinical correlations.
Bloom SR; Yiangou Y; Polak JM
Ann N Y Acad Sci; 1988; 527():518-27. PubMed ID: 2839088
[No Abstract] [Full Text] [Related]
37. Amelioration of symptoms and reduction of VIP levels after hepatic artery chemoembolization in a patient with sandostatin resistant VIPoma.
Shaib W; Mitchell K; Saif MW
Yale J Biol Med; 2010 Mar; 83(1):27-33. PubMed ID: 20351979
[TBL] [Abstract][Full Text] [Related]
38. [VIPoma of the Pancreas].
Steck A; Nebiker C; Capraro J; Yurtsever H; Toutonji AA; Struja T
Praxis (Bern 1994); 2021 Sep; 110(11):637-642. PubMed ID: 34465193
[TBL] [Abstract][Full Text] [Related]
39. [Hypokalemia and intestinal pseudo-obstruction in a 57-year-old male. Surgically confirmed VIPoma with reference to therapy with somatostatin].
Koberstein B; Balzer K; Müller MK; Eysselein VE; Singer MV; Goebell H
Med Klin (Munich); 1988 Mar; 83(7):251-6. PubMed ID: 2898092
[No Abstract] [Full Text] [Related]
40. Treatment of metastatic Vipoma by liver transplantation.
Bramley PN; Lodge JP; Losowsky MS; Giles GR
Clin Transplant; 1990 Oct; 4(5 part 1):276-8; discussion 279. PubMed ID: 10150088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
